Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
PLoS One ; 11(6): e0156127, 2016.
Article in English | MEDLINE | ID: mdl-27276221

ABSTRACT

Liver transplantation for hilar cholangiocarcinoma (hCCA) has regained attention since the Mayo Clinic reported their favorable results with the use of a neo-adjuvant chemoradiation protocol. However, debate remains whether the success of the protocol should be attributed to the neo-adjuvant therapy or to the strict selection criteria that are being applied. The aim of this study was to investigate the value of patient selection alone on the outcome of liver transplantation for hCCA. In this retrospective study, patients that were transplanted for hCCA between1990 and 2010 in Europe were identified using the European Liver Transplant Registry (ELTR). Twenty-one centers reported 173 patients (69%) of a total of 249 patients in the ELTR. Twenty-six patients were wrongly coded, resulting in a study group of 147 patients. We identified 28 patients (19%) who met the strict selection criteria of the Mayo Clinic protocol, but had not undergone neo-adjuvant chemoradiation therapy. Five-year survival in this subgroup was 59%, which is comparable to patients with pretreatment pathological confirmed hCCA that were transplanted after completion of the chemoradiation protocol at the Mayo Clinic. In conclusion, although the results should be cautiously interpreted, this study suggests that with strict selection alone, improved survival after transplantation can be achieved, approaching the Mayo Clinic experience.


Subject(s)
Bile Duct Neoplasms , Klatskin Tumor , Liver Transplantation , Patient Selection , Registries , Adult , Bile Duct Neoplasms/mortality , Bile Duct Neoplasms/surgery , Disease-Free Survival , Female , Follow-Up Studies , Humans , Klatskin Tumor/mortality , Klatskin Tumor/surgery , Male , Middle Aged , Survival Rate
2.
Cancer Med ; 5(7): 1373-80, 2016 07.
Article in English | MEDLINE | ID: mdl-27062713

ABSTRACT

Frozen section analysis (FS) during cancer surgery is widely used to assess resection margins. However, in hilar cholangiocarcinoma (HCCA), FS may be less reliable because of the specific growth characteristics of the tumor. The aim of this study was to determine the accuracy and consequences of intraoperative FS of the proximal bile duct margins in HCCA. Between 1990 and 2014, 67 patients underwent combined extrahepatic bile duct resection and partial liver resection for HCCA with the use of FS. Sensitivity and specificity of FS was 68% and 97%, respectively. Seventeen of 67 patients (25%) displayed a positive bile duct margin at FS. The false-negative rate was 16% (eight patients). Ten patients (15%) with a positive bile duct margin underwent an additional resection in an attempt to achieve negative margins, which succeeded in three patients (4%). However, only one of these three patients did not have concomitant lymph node metastases, which are associated with a poor prognosis by itself. The use of FS of the proximal bile duct is of limited clinical value because of the relatively low sensitivity, high risk of false-negative results, and the low rate of secondary obtained tumor-free resection margins. Supported by the literature, a new approach to the use of FS in HCCA should be adopted, reserving the technique only for cases in which a substantial additional resection is possible.


Subject(s)
Bile Duct Neoplasms/diagnosis , Bile Ducts, Extrahepatic/pathology , Frozen Sections , Klatskin Tumor/diagnosis , Aged , Bile Duct Neoplasms/mortality , Bile Duct Neoplasms/surgery , Biopsy , Female , Frozen Sections/methods , Hepatectomy , Hospital Mortality , Humans , Intraoperative Period , Klatskin Tumor/mortality , Klatskin Tumor/surgery , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Prognosis , Reproducibility of Results
3.
Ann Surg Oncol ; 22 Suppl 3: S1107-15, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26178761

ABSTRACT

BACKGROUND: Lymph node metastases on routine histology are a strong negative predictor for survival after resection of hilar cholangiocarcinoma. Additional immunohistochemistry can detect lymph node micrometastases in patients who are otherwise node negative, but the prognostic value is unsure. The objective of this study was to assess the effect on survival of immunohistochemically detected lymph node micrometastases in patients with node-negative (pN0) hilar cholangiocarcinoma on routine histology. METHODS: Between 1990 and 2010, a total of 146 patients underwent curative-intent resection of hilar cholangiocarcinoma with regional lymphadenectomy at two university medical centers in the Netherlands. Ninety-one patients (62 %) without lymph node metastases at routine histology were included. Micrometastases were identified by multiple sectioning of all lymph nodes and additional immunostaining with an antibody against cytokeratin 19 (K19). The association with overall survival was assessed in univariable and multivariable analysis. Median follow-up was 48 months. RESULTS: Micrometastases were identified in 16 (5 %) of 324 lymph nodes, corresponding to 11 (12 %) of 91 patients. There were no differences in clinical variables between K19 lymph node-positive and -negative patients. Five-year survival rates in patients with lymph node micrometastases were significantly lower compared to patients without micrometastases (27 vs. 54 %, P = 0.01). Multivariable analysis confirmed micrometastases as an independent prognostic factor for survival (adjusted Hazard ratio 2.4, P = 0.02). CONCLUSIONS: Lymph node micrometastases are associated with worse survival after resection of hilar cholangiocarcinoma. Immunohistochemical detection of lymph node micrometastases leads to better staging of patients who were initially diagnosed with node-negative (pN0) hilar cholangiocarcinoma on routine histology.


Subject(s)
Bile Duct Neoplasms/mortality , Bile Ducts, Intrahepatic/pathology , Cholangiocarcinoma/mortality , Lymph Nodes/pathology , Neoplasm Recurrence, Local/mortality , Adult , Aged , Bile Duct Neoplasms/metabolism , Bile Duct Neoplasms/secondary , Bile Ducts, Intrahepatic/metabolism , Biomarkers, Tumor/metabolism , Cholangiocarcinoma/metabolism , Cholangiocarcinoma/pathology , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , Lymph Nodes/metabolism , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Recurrence, Local/metabolism , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Prognosis , Survival Rate
4.
Contraception ; 87(1): 121-3, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22974596

ABSTRACT

BACKGROUND: We present a rare but serious complication of Essure microinsert sterilization. STUDY DESIGN: Case report. RESULTS: A 42-year-old woman presented with nausea, vomiting, abdominal pain and abdominal distension 1 month after uncomplicated Essure sterilization. Abdominal X-ray showed small bowel obstruction. At subsequent laparotomy, a stretched Essure device was found ensnaring the terminal ileum. It had caused strangulation and local perforation of the bowel wall. The device was removed and an ileocecal resection with side-to-side ileocolostomy was performed. In retrospect, the aberrant location of the right Essure device near the ileocecal junction was noticed on the abdominal X-ray. CONCLUSIONS: This case illustrates that perforation of an Essure device can result in a serious complication leading to ileocecal resection. An abdominal X-ray with specific attention to the correct location of the Essure coils is advisable for patients presenting with small bowel obstruction after Essure sterilization.


Subject(s)
Cecal Diseases/etiology , Ileal Diseases/etiology , Intestinal Obstruction/etiology , Intestinal Perforation/etiology , Prosthesis Failure/adverse effects , Sterilization, Reproductive/adverse effects , Adult , Cecal Diseases/surgery , Female , Humans , Ileal Diseases/surgery , Intestinal Obstruction/surgery , Intestinal Perforation/surgery
5.
Liver Transpl ; 13(10): 1372-81, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17427173

ABSTRACT

Liver transplantation after neoadjuvant chemoradiotherapy has emerged as an effective treatment for patients with localized, node-negative, unresectable hilar cholangiocarcinoma (CCA) or CCA arising in the setting of primary sclerosing cholangitis (PSC). However, concern has arisen regarding the potential for vascular complications due to high-dose neoadjuvant therapy before transplantation. We reviewed our experience with specific aims to determine the incidences of arterial, portal, and hepatic venous complications in patients transplanted for CCA compared with patients who undergo transplantation for other indications, and to describe patient outcome as a result of these vascular complications. We reviewed data for all patients who underwent liver transplantation for CCA between January 1993 and April 2006 and compared the incidences of vascular complications to whole organ and living donor recipient control groups. Sixty-eight patients underwent neoadjuvant therapy and subsequent liver transplantation. Arterial complications arose in 21%; portal venous complications arose in 22%; and overall, 40% developed vascular complications. Late hepatic artery complications occurred more often in living donor recipients transplanted for CCA compared with the living donor control group (P=0.047). Late portal vein complications occurred more often in both whole organ and living donor recipients transplanted for CCA compared with the control groups (P=0.01 and P=0.009). Hepatic venous complications were rare. Patient and graft survival were not different between CCA and control patients. Liver transplantation with neoadjuvant therapy is associated with far higher rates of late arterial and portal venous complications, but these complications do not adversely affect patient and graft survival.


Subject(s)
Antineoplastic Agents/adverse effects , Bile Duct Neoplasms/therapy , Bile Ducts, Intrahepatic , Cholangiocarcinoma/therapy , Graft Occlusion, Vascular/etiology , Liver Transplantation/adverse effects , Adult , Aged , Antineoplastic Agents/therapeutic use , Bile Duct Neoplasms/drug therapy , Bile Duct Neoplasms/radiotherapy , Bile Duct Neoplasms/surgery , Cholangiocarcinoma/drug therapy , Cholangiocarcinoma/radiotherapy , Cholangiocarcinoma/surgery , Female , Graft Occlusion, Vascular/diagnosis , Graft Survival , Humans , Male , Middle Aged , Neoadjuvant Therapy , Postoperative Complications , Radiotherapy, Adjuvant/adverse effects , Treatment Outcome , Ultrasonography, Doppler, Duplex
SELECTION OF CITATIONS
SEARCH DETAIL
...